TAK

Takeda Pharmaceutical Company Limited (TSE:4502) is a Japanese multinational pharmaceutical company founded in 1781, making it one of the oldest pharmaceutical companies in the world. Originally established as a traditional medicine shop in Osaka, Takeda has evolved into a global biopharmaceutical leader headquartered in Tokyo. The company operates across major markets including Japan, the United States, Europe, and other international regions, focusing on research, development, manufacturing, and marketing of innovative pharmaceutical products. Following its transformative $62 billion acquisition of Shire plc in 2019, Takeda has positioned itself as a leading player in specialized therapeutic areas including gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience.